Advancells, a leader in regenerative medicine, is excited to announce the development of a groundbreaking stem cell therapy for individuals living with Multiple Sclerosis (MS).

Parkinson's disease does not frequently affect individuals under the age of 50, although, for a tiny percentage of patients, the condition can manifest in their earlier years.